Welcome to the latest edition of our weekly EuroBiotech Report. We lead this week on news that Neil Woodford’s much-discussed fund is starting to take shape, with a $50 million (€36.8 million) investment in Elan-spinoff Prothena among its first batch of positions. And more.

…read more

Source: Woodford buys $50M Prothena stake, Shire lacks ‘British gem’ status, French biotechs raise €100M


0 No comments